力博医药 (839732.OC)

+ 收藏

现金流量表(力博医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 96,950,354.20198,148,896.2477,924,947.43171,357,170.6668,113,359.67
 收到的税费返还(元) ---203,972.4017,270.41
 收到其他与经营活动有关的现金(元) 2,498,821.905,442,988.531,249,615.133,614,643.33905,886.20
 经营活动现金流入小计(元) 99,449,176.10203,591,884.7779,174,562.56175,175,786.3969,036,516.28
 购买商品、接受劳务支付的现金(元) 30,330,416.9762,976,268.2234,750,568.4968,714,746.8626,943,415.91
 支付给职工以及为职工支付的现金(元) 26,641,433.1340,463,249.4919,943,916.8835,684,180.0121,140,258.43
 支付的各项税费(元) 8,109,141.1115,068,547.598,882,214.557,431,907.093,024,044.21
 支付其他与经营活动有关的现金(元) 18,572,429.4237,335,178.0216,345,166.0827,942,224.5612,103,140.90
 经营活动现金流出小计(元) 83,653,420.63155,843,243.3279,921,866.00139,773,058.5263,210,859.45
 经营活动产生的现金流量净额(元) 15,795,755.4747,748,641.45-747,303.4435,402,727.875,825,656.83
二、投资活动产生的现金流量
 取得投资收益收到的现金(元) -46,103.63-6,565.63-
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 4,955.754,282.17-69,690.78-
 收到其他与投资活动有关的现金(元) 20,000,000.0011,936,516.9311,936,516.93--
 投资活动现金流入小计(元) 20,004,955.7511,986,902.7311,936,516.9376,256.41-
 购建固定资产、无形资产和其他长期资产支付的现金(元) 24,045,906.4421,800,908.086,371,716.4332,719,167.8918,602,321.41
 取得子公司及其他营业单位支付的现金净额(元) -17,000,000.0017,000,000.00--
 支付其他与投资活动有关的现金(元) -20,000,000.00---
 投资活动现金流出小计(元) 24,045,906.4458,800,908.0823,371,716.4332,719,167.8918,602,321.41
 投资活动产生的现金流量净额(元) -4,040,950.69-46,814,005.35-11,435,199.50-32,642,911.48-18,602,321.41
三、筹资活动产生的现金流量
 支付其他与筹资活动有关的现金(元) 450,963.3816,000,391.99408,343.43732,477.48396,706.89
 筹资活动现金流出小计(元) 450,963.3816,000,391.99408,343.43732,477.48396,706.89
 筹资活动产生的现金流量净额(元) -450,963.38-16,000,391.99-408,343.43-732,477.48-396,706.89
五、现金及现金等价物净增加额(元) 11,303,841.40-15,065,755.89-12,590,846.372,027,338.91-13,173,371.47
 加:期初现金及现金等价物余额(元) 32,543,003.1747,608,759.0647,608,759.0645,581,420.1545,581,420.15
 期末现金及现金等价物余额(元) 43,846,844.5732,543,003.1735,017,912.6947,608,759.0632,408,048.68
补充资料:
 净利润(元) 12,946,752.0235,826,961.7712,419,337.6237,179,002.1711,466,298.70
 资产减值准备(元) --354,994.01-13,553.18130,822.38
 固定资产和投资性房地产折旧(元) 9,368,451.7917,969,315.728,607,329.2216,802,007.218,351,342.15
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 9,368,451.7917,969,315.728,607,329.2216,802,007.218,351,342.15
 无形资产摊销(元) 1,496,621.331,626,197.01124,075.80247,192.90123,117.10
 长期待摊费用摊销(元) 4,835,262.787,747,921.554,391,927.165,062,625.721,309,943.64
 处置固定资产、无形资产和其他长期资产的损失(元) -4,955.75-1,376.57-7,095.71-38,558.41
 固定资产报废损失(元) -250.20-9,252.72-
 财务费用(元) 17,513.0849,098.0332,529.2081,895.1046,946.82
 投资损失(元) --46,103.63--6,565.63-
 递延所得税(元) -1,070,834.36-2,874,963.40115,124.95-1,978,082.3067,806.60
  其中:递延所得税资产减少(元) -574,429.92-2,363,033.07115,124.95-1,978,082.3067,806.60
 递延所得税负债增加(元) -496,404.44-511,930.33---
 存货的减少(元) -2,794,964.65-16,665,862.77-20,060,246.35-19,739,411.55-5,117,520.26
 经营性应收项目的减少(元) 1,963,354.7612,782,192.1613,250,286.17-2,732,262.22-5,163,645.12
 经营性应付项目的增加(元) -11,303,873.90-8,885,918.35-19,982,661.22483,531.22-5,350,896.77
 不涉及现金收支的投资和筹资活动金额其他项目(元) -141,838.88306,505.641,986,873.151,831,719.86
 现金的期末余额(元) 43,846,844.5732,543,003.1735,017,912.6947,608,759.0632,408,048.68
 减:现金的期初余额(元) 32,543,003.1747,608,759.0647,608,759.0645,581,420.1545,581,420.15
 现金及现金等价物的净增加额(元) 11,303,841.40-15,065,755.89-12,590,846.372,027,338.91-13,173,371.47
公告日期 2024-08-262024-04-292023-08-282023-04-252022-08-31
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院